Biotest
Vera Ott's work experience includes various roles at different companies. Vera started their career at Universität zu Köln as a Post Doc from August 2008 to February 2009. Vera then joined Biotest AG, where they worked as the Director of Process Optimization from February 2012 to August 2018. After that, they became the Project Leader for Development Projects from September 2018 to December 2019. Currently, they hold the position of Leitung Produktion 2/VP Production 2 at Biotest AG since January 2020.
Vera Ott obtained a Diplom degree in Biology from the University of Cologne between 1999 and 2005. Vera then pursued a Dr. rer. nat. degree in Biochemistry at the same university from 2005 to 2008.
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.